Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
44%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
41%
ALSO IN XLV
XLV
59
HOLDINGS
19%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus XLV)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in XLV |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 19.1% | 16.1% | 16.1% |
|
ABBVIE INC | 9.5% | 7.8% | 7.8% |
|
JOHNSON & JOHNSON | 6.0% | 10.8% | 6.0% |
|
MERCK & CO. INC. | 4.2% | 5.5% | 4.2% |
|
AMGEN INC | 4.2% | 3.5% | 3.5% |
MEDX Overweight Relative to XLV
 |
NOVARTIS AG-ADR | 7.1% |
 |
ALKERMES PLC | 5.8% |
 |
ASTRAZENECA PLC | 4.6% |
|
IONIS PHARMACEUTICALS, INC. | 3.4% |
|
ALNYLAM PHARMACEUTICALS INC | 3.2% |
|
ELI LILLY & CO | 3.0% |
|
BRISTOL-MYERS SQUIBB CO | 2.8% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 2.7% |
|
BIOGEN IDEC INC | 2.5% |
|
CRISPR THERAPEUTICS AG | 2.3% |
MEDX Underweight Relative to XLV
|
UNITEDHEALTH GROUP INC | -6.5% |
|
JOHNSON & JOHNSON | -4.8% |
|
THERMO FISHER SCIENTIFIC INC | -3.6% |
|
ABBOTT LABORATORIES | -3.1% |
|
GILEAD SCIENCES INC | -2.7% |
|
CVS CAREMARK CORP | -2.3% |
|
VERTEX PHARMACEUTICALS INC | -2.1% |
|
DANAHER CORP | -2.1% |
|
INTUITIVE SURGICAL INC | -2.0% |
|
STRYKER CORP | -1.9% |